ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

231 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Nigella Sativa Oil for Eczematous Otitis Externa

N/AEczema/Atopic DermatitisOtitis Externa

Mometasone Furoate (MF)Nigella sativa oil

Bezmialem Vakif University85 participants1 site · Turkey (Türkiye)Completes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Prospective Longitudinal Observational Research in Atopic Dermatitis

N/AAtopic DermatitisAsthmaAtopic Dermatitis and Related Conditions

University of Zurich1,000 participants1 site · SwitzerlandCompletes Mar 2031

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

N/AAtopic DermatitisEczema

Abrocitinib

Pfizer183 participants30 sites · FranceCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

Phase 4Lichen Plano-Pilaris

Nemolizumab

The Skin Center Dermatology Group10 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of Chronic Hand Eczema

N/AChronic Hand EczemaAtopic Dermatitis

Tape stripping

Dr. Robert Bissonnette270 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

Placebo ComparatorCM512

Keymed Biosciences Co.Ltd200 participants1 site · ChinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

N/ACutaneous T Cell Lymphoma

Northwestern University300 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

N/AAutoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases

Blood samplingRemainders of samples taken as part of the treatment

University Hospital, Toulouse800 participants1 site · FranceCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

Immune-supportive Diet and Gut Permeability in Allergic Children

N/APeanut AllergyNut Allergy

Immune-supportive dietStandard care

Onze Lieve Vrouwe Gasthuis132 participants1 site · NetherlandsCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Phase 1Dermatitis, Atopic

DCY636Placebo

Novartis Pharmaceuticals63 participants1 site · JapanCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

N/AAcneAtopic DermatitisChronic Hand Eczema

Blood samples collectionOral samples collectionHair samples collection+4 more

Innovaderm Research Inc.500 participants1 site · CanadaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

DupilumabPlaceboIBI356

Innovent Biologics (Suzhou) Co. Ltd.403 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Phase 1Cutaneous Metastases

Diphencyprone (DPCP)

Nicholas Gulati100 participants1 site · United StatesCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Phase 1Moderate-to-severe Atopic Dermatitis

TRB-061TRB-061TRB-061+1 more

TRex Bio, Inc.115 participants19 sites · Australia, New ZealandCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 231

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

231 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Nigella Sativa Oil for Eczematous Otitis Externa

N/AEczema/Atopic DermatitisOtitis Externa

Mometasone Furoate (MF)Nigella sativa oil

Bezmialem Vakif University85 participants1 site · Turkey (Türkiye)Completes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Prospective Longitudinal Observational Research in Atopic Dermatitis

N/AAtopic DermatitisAsthmaAtopic Dermatitis and Related Conditions

University of Zurich1,000 participants1 site · SwitzerlandCompletes Mar 2031

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

N/AAtopic DermatitisEczema

Abrocitinib

Pfizer183 participants30 sites · FranceCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

Phase 4Lichen Plano-Pilaris

Nemolizumab

The Skin Center Dermatology Group10 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of Chronic Hand Eczema

N/AChronic Hand EczemaAtopic Dermatitis

Tape stripping

Dr. Robert Bissonnette270 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

Placebo ComparatorCM512

Keymed Biosciences Co.Ltd200 participants1 site · ChinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

N/ACutaneous T Cell Lymphoma

Northwestern University300 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

N/AAutoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases

Blood samplingRemainders of samples taken as part of the treatment

University Hospital, Toulouse800 participants1 site · FranceCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

Immune-supportive Diet and Gut Permeability in Allergic Children

N/APeanut AllergyNut Allergy

Immune-supportive dietStandard care

Onze Lieve Vrouwe Gasthuis132 participants1 site · NetherlandsCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Phase 1Dermatitis, Atopic

DCY636Placebo

Novartis Pharmaceuticals63 participants1 site · JapanCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

N/AAcneAtopic DermatitisChronic Hand Eczema

Blood samples collectionOral samples collectionHair samples collection+4 more

Innovaderm Research Inc.500 participants1 site · CanadaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

DupilumabPlaceboIBI356

Innovent Biologics (Suzhou) Co. Ltd.403 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Phase 1Cutaneous Metastases

Diphencyprone (DPCP)

Nicholas Gulati100 participants1 site · United StatesCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Phase 1Moderate-to-severe Atopic Dermatitis

TRB-061TRB-061TRB-061+1 more

TRex Bio, Inc.115 participants19 sites · Australia, New ZealandCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 231